Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_assertion type Assertion NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_head.
- NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_assertion description "[In primary samples at diagnosis, miR-124-1 methylation was absent in CML but detected in 2% each of MM at diagnosis and relapse/progression, 5% ALL, 15% AML, 14% CLL and 58.1% of NHL (p<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_provenance.
- NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_assertion evidence source_evidence_literature NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_provenance.
- NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_assertion SIO_000772 21544199 NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_provenance.
- NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_assertion wasDerivedFrom befree-20150227 NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_provenance.
- NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_assertion wasGeneratedBy ECO_0000203 NP992991.RAoy5BwqeE8EPtJ8DGh57pxF3L_NESkrGBfxoV5Ppkl9Q130_provenance.